Albany Cancer Center - Patroon Creek office has reopened. Use lower lot entrance for all appointments.
Albany Medical Center patients should continue to use upper lot entrance to check in for appointments in Suite 210.
Radiation, PET and CT patients use radiation entrance in lower lot. Learn More

Clinical Trials & Research

Ph3 Infigratinib UC w/ FGFR3 Alt

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

Disease Types: Bladder,&nbs

Available at: {clinical_trial_location backspace="7"}Ph3 Infigratinib UC w/ FGFR3 Alt, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}